Skip to Content

Join the 'Opdivo' group to help and get support from people like you.

Opdivo Support Group


Our support group for Opdivo has 16 questions and 19 members. Updated 17 Jan 2017.

Latest News

Bristol-Myers Squibb’s Opdivo (nivolumab) is the First Immuno-Oncology Treatment to Receive FDA Approval Based on Overall Survival in Head and Neck Cancer

PRINCETON, N.J.--(BUSINESS WIRE) November 10, 2016 --Bristol-Myers Squibb Company (NYSE:BMY) announced today that the U.S. Food and Drug Administration (FDA) has approved Opdivo (nivolumab) ...

Read more news...

Latest Questions

View more questions...

Further Information

Related Condition Support Groups

Non-Small Cell Lung Cancer, Renal Cell Carcinoma, Melanoma, Hodgkin's Lymphoma, Melanoma - Metastatic, Head and Neck Cancer

Opdivo Patient Information at

Ask a Question

Top Group Members

2 total answers
In this group:
0 answer
1 total answer
In this group:
0 answer
14,356 answers
3,801 answers
91 answers
1 answer

View all 19 members...